1. Home
  2. IKT vs CPOP Comparison

IKT vs CPOP Comparison

Compare IKT & CPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • CPOP
  • Stock Information
  • Founded
  • IKT 2008
  • CPOP 2007
  • Country
  • IKT United States
  • CPOP China
  • Employees
  • IKT N/A
  • CPOP N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • CPOP Services-Misc. Amusement & Recreation
  • Sector
  • IKT Health Care
  • CPOP Consumer Discretionary
  • Exchange
  • IKT Nasdaq
  • CPOP Nasdaq
  • Market Cap
  • IKT 140.5M
  • CPOP 123.9M
  • IPO Year
  • IKT 2020
  • CPOP 2021
  • Fundamental
  • Price
  • IKT $1.56
  • CPOP $1.68
  • Analyst Decision
  • IKT Buy
  • CPOP
  • Analyst Count
  • IKT 2
  • CPOP 0
  • Target Price
  • IKT $8.00
  • CPOP N/A
  • AVG Volume (30 Days)
  • IKT 92.1K
  • CPOP 1.4M
  • Earning Date
  • IKT 11-13-2025
  • CPOP 11-14-2025
  • Dividend Yield
  • IKT N/A
  • CPOP N/A
  • EPS Growth
  • IKT N/A
  • CPOP N/A
  • EPS
  • IKT N/A
  • CPOP N/A
  • Revenue
  • IKT N/A
  • CPOP $65,186,721.00
  • Revenue This Year
  • IKT N/A
  • CPOP N/A
  • Revenue Next Year
  • IKT N/A
  • CPOP N/A
  • P/E Ratio
  • IKT N/A
  • CPOP N/A
  • Revenue Growth
  • IKT N/A
  • CPOP 108.29
  • 52 Week Low
  • IKT $1.12
  • CPOP $0.46
  • 52 Week High
  • IKT $4.20
  • CPOP $2.47
  • Technical
  • Relative Strength Index (RSI)
  • IKT 42.51
  • CPOP 73.15
  • Support Level
  • IKT $1.50
  • CPOP $1.51
  • Resistance Level
  • IKT $1.73
  • CPOP $1.79
  • Average True Range (ATR)
  • IKT 0.09
  • CPOP 0.20
  • MACD
  • IKT -0.02
  • CPOP 0.03
  • Stochastic Oscillator
  • IKT 17.34
  • CPOP 54.86

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

Share on Social Networks: